November 21 2017

About NanoApps Medical Inc

NanoApps Medical, Inc. was incorporated in 2009 with the goal of developing advanced nanomedical diagnostic and therapeutic technologies for the benefit of individuals across both the developing and developed worlds.

The larger picture will be to eventually attain a situation of “Global Health Care Equivalency” (GHCE) where any individual on the planet may have access to the same advanced, high quality, and cost effective nanomedical diagnostic and therapeutic technologies, no matter where they happen to reside, or under what conditions they live. Boehm is now compiling a book that will articulate this grand vision.

Further, NanoApps Medical is ambitiously aiming to transition terrestrial nanomedicine to space applications to facilitate future Lunar and Mars missions, such as those being boldly planned by NASA and SpaceX.

Read More

 

 

Potential Nanomedical Countermeasures to Mitigate the Effects of Space on Humans

Incremental progress has been made on several fronts that may employ nanomedical strategies, to potentially counteract the deleterious effects of galactic cosmic rays and microgravity on human physiology.  The implementation of these strategies and the enhancement of their preventative, diagnostic, or therapeutic effects for future orbital, planetary, and deep space missions might be enabled via diverse and potent synergies between unique nanomedical applications of nanomaterials and nanotechnologies.

 

Read More

 

 

NanoApps Medical, Inc. Aiming to Develop Nanobiosensor for Malaria, Ebola, and Zika

NanoApps Medical, Inc. (Vancouver, Canada) is working to develop a point of care diagnostic nanobiosensor platform for the detection of Malaria via saliva samples, which may be reconfigured to detect Ebola, and Zika. The use of this nanobiosensor will be far less invasive and safer than through the extraction of blood samples, while conveying more rapid results.

The current gold standard for the detection of Malaria is blood smear microscopy, the results of which may take from many hours to several days to determine. This test also has the requirements of technical expertise in blood sample preparation, and a trained microscopist. Hence, the proposed nanobiosensor would be a significant improvement in terms of expediting and simplifying the diagnosis of Malaria, Ebola, and Zika in that it would be easy to administer, and provide rapid and clearly understandable results.

Read More

 

 

Frank Boehm represents Alias Studio Sydney in North America

From Alias Studio Sydney:

To better serve our new Aerospace, Nanotechnology, and Nanomedicine clients we are pleased to engage Frank Boehm of Vancouver Canada to represent Alias in North America.

A true entrepreneur and author of the respected reference book: Nanomedical Device and Systems Design: Challenges, Possibilities, Visions, Frank is the CEO of NanoApps Medical Inc.

Read More

 

 

Nanomedical Device and Systems Design: Challenges, Possibilities, Visions by Frank Boehm

Nanomedical Device and Systems Design: Challenges, Possibilities, Visions by Frank Boehm of NanoApps Medical Inc. serves as a preliminary guide toward the inspiration of specific investigative pathways that may lead to meaningful discourse and significant advances in nanomedicine/nanotechnology.

This volume considers the potential of future innovations that will involve nanomedical devices and systems. It endeavors to explore remarkable possibilities spanning medical diagnostics, therapeutics, and other advancements that may be enabled within this discipline.

In particular, this book investigates just how nanomedical diagnostic and therapeutic devices and systems might ultimately be designed and engineered to accurately diagnose and eradicate pathogens, toxins, and myriad disease states.

Read More

 

 

Nanotechnology, Nanomedicine, and AI: Toward the Dream of Global Health Care Equivalency

Synergies between nanotechnology, nanomedicine, and AI may enable this vision on a global scale. Progress toward this goal will be incremental, with each successive wave of nanomedical technologies being more advanced than the previous wave. The tipping point will arrive with the emergence of Molecular Manufacturing (MM)which will make possible the economical fabrication of the types of advanced autonomous nanomedical devices that are described in Frank’s initial book: Nanomedical Device and Systems Design: Challenges, Possibilities, Visions

NanoApps Medical keenly recognizes that such a massive undertaking on a global scale will require intense and high spirited collaboration with like minded individuals, research labs, institutions, organizations, and government agencies worldwide for its realization. It will also require significant resources and time.

Read More

 

 

News

Nanoparticles could allow for faster, better medicine

Gold nanoparticles could help make drugs act more quickly and effectively, according to new research conducted at Binghamton University, State University of New York. Nanoparticles are microscopic particles that are bigger than atoms but smaller [...]

Breakthrough discovery in diagnostic tools that can replace commonly used and fragile antibodies

Experts from the Biotechnology Group at the University of Leicester led by Professor Sergey Piletsky in collaboration with the spin-off company MIP Diagnostics Ltd have announced the development of polymeric materials with molecular recognition capabilities [...]

Breakthrough could launch organic electronics beyond cell phone screens

A discovery by an international team of researchers from Princeton University, the Georgia Institute of Technology and Humboldt University in Berlin points the way to more widespread use of an advanced technology generally known as [...]

Nanowired Drugs for Treating Alzheimer’s and Parkinson’s Diseases

Millions of Americans suffer from neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Researchers have identified new treatments, such as cerebrolysin, which are promising, but present clinical approaches are ineffective as critical concentrations of the drug [...]

Nanotechnology might help farmers fight climate change, pests and disease–and boost yields

The sun is strong, the sky Hollywood-set blue, but the wind is brutal. This is confounding the work of Wade Elmer, chief scientist for the Department of Plant Pathology and Ecology at the Connecticut Agricultural [...]

New Study Highlights Bone-Targeted Nanoparticle Treatment for Prostate Cancer

In certain patients, castrate-resistant or metastatic prostate cancer can spread to the bone. Although many new treatments are available, they can have a hard time reaching the bone and frequently result in missing the metastatic [...]

Next-generation optogenetic molecules control single neurons

Researchers at MIT and Paris Descartes University have developed a new optogenetic technique that sculpts light to target individual cells bearing engineered light-sensitive molecules, so that individual neurons can be precisely stimulated. Until now, it [...]

Zipping DNA

What do you do if you have a large document or a high-resolution image that is too big to send via email? You simply zip it to a more manageable size using a suitable software. [...]

Nanoparticles can limit inflammation by distracting the immune system

A surprise finding suggests that an injection of nanoparticles may be able to help fight the immune system when it goes haywire, researchers at the University of Michigan have shown (ACS Nano, "Neutrophil-particle interactions in [...]

New Research on Nanotechnology Drug Delivery Market: Studying Influencing Factors and Key Players

Nanotechnology Drug Delivery mainly used in healthcare applications such as such as neurology, anti-infective, cardiovascular disorders, and others. They are part of active application of the transport drugs to the final location of therapeutic intervention [...]

Researchers Develop Polymer Nanoagents to Light Up Tiny Areas of Diseased Tissues

Polymer nanoagents capable of ‘lighting up’ small areas of diseased tissues that standard methods fail to detect, have been developed by a research team headed by Nanyang Technological University, Singapore (NTU Singapore). The nanoagents, called [...]

Scientists create ‘tracking’ nanoagents to illuminate very small diseased tissues

Polymer nanoagents that can 'light up' tiny areas of diseased tissues that conventional methods fail to detect, have been created by a research team led by Nanyang Technological University, Singapore (NTU Singapore) The nanoagents, known [...]

NanoApps Medical Inc. Near-Term Projects

NanoApps Medical is aiming to investigate the possibility that superparamagnetic nanoparticles (SPIONs) and other classes of nanoparticles (e.g., gold coated nanoshells) might have the capacity to target cancerous tumors, metastasizing cancer cells, pathogens, etc. to deactivate/eliminate them via hypothermia.

Read More

 

 

 

NanoMedicine and Human Spaceflight

Future nanomedical devices and systems will have strong potential to enable a broad range of aerospace and space applications. With further dimensional reductions in conjunction with the increased capabilities of nanoelectronics and artificial intelligence (AI), nanomedicine may facilitate the development of a wide array of advanced nanomedical diagnostic and therapeutic capabilities dedicated to the health and well being of future astronauts and space pioneers, the inhabitants of future Lunar and Mars colonies, and deep space explorers.

 

Read More

 

 

Ocular and Cellular Anomalies

Microgravity induced ophthalmic anomalies were observed by Mader et al in seven astronauts who were involved in long-duration (six month) space missions to the ISS. An additional 300 astronauts were asked to complete a questionnaire in regard to in-flight vision changes. For the seven astronauts under study, the ophthalmic results indicated disk edema (in five), globe flattening (in five), choroidal folds (in five), cotton wool spots (in three), nerve fiber layer thickening (in six), decreased near-vision (in six). Further, optic nerve sheath distension and tortuous optic nerves were observed.

Of the 300 questionnaire respondents, 60% of the astronauts who were engaged in long duration missions reported experiencing degradation in both their near and distance vision; these conditions persisted for years postflight for some individuals.

Read More

 

 

Cardiac Function and Muscle Atrophy

In 2004, NASA released its Bioastronautics Critical Path Roadmap (BCPR), with an aim to “establish tolerance limits to the space environment and develop countermeasures to overcome these problems.” The BCPR listed close to 50 space-related medical risk factors, which included those associated with the potential for serious cardiac dysrhythmias (from unknown causes) that may lead to hypotension (low blood pressure) and syncope (fainting). Further, significant cardiac rhythm issues (e.g., ventricular tachycardia – rapid heartbeat), linked with altered cardiac electrical activity and stability were reported for a number of cases during a MIR mission.

Degraded cardiac and vascular functionality, as well as decreased cardiac mass can result from both short and long duration spaceflight.

Read More